What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Cancer research, Pharmacology, Biochemistry, Cancer and Apoptosis.
His studies in Cancer research integrate themes in fields like Endocrinology, Carcinogenesis, Internal medicine and LNCaP, Prostate cancer.
His study on Tumor promotion is often connected to Vascular endothelial growth factor as part of broader study in Carcinogenesis.
The study incorporates disciplines such as Inflammation, In vivo, Antioxidant and Anticarcinogen in addition to Pharmacology.
His Cancer research includes elements of Lung cancer, Pathology and Traditional medicine.
His work carried out in the field of Apoptosis brings together such families of science as Cancer cell, Molecular biology and Cell growth.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Tea polyphenols for health promotion (769 citations)
- Green Tea Constituent Epigallocatechin-3-Gallate and Induction of Apoptosis and Cell Cycle Arrest in Human Carcinoma Cells (698 citations)
What are the main themes of his work throughout his whole career to date?
Hasan Mukhtar spends much of his time researching Cancer research, Biochemistry, Cancer, Pharmacology and Internal medicine.
He has included themes like Apoptosis, Protein kinase B, Cell growth, Carcinogenesis and Cancer cell in his Cancer research study.
His study focuses on the intersection of Biochemistry and fields such as Molecular biology with connections in the field of Human skin and Epidermis.
The various areas that Hasan Mukhtar examines in his Cancer study include Green tea and Pathology.
He works mostly in the field of Pharmacology, limiting it down to concerns involving Polyphenol and, occasionally, GTP'.
His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Oncology.
He most often published in these fields:
- Cancer research (32.36%)
- Biochemistry (39.21%)
- Cancer (18.95%)
What were the highlights of his more recent work (between 2013-2021)?
- Cancer research (32.36%)
- Cancer (18.95%)
- Fisetin (6.12%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Cancer, Fisetin, Prostate cancer and Pharmacology.
Hasan Mukhtar combines subjects such as Apoptosis, PI3K/AKT/mTOR pathway, PTEN and Immunology with his study of Cancer research.
His study in Apoptosis is interdisciplinary in nature, drawing from both Cytotoxic T cell, Cell growth and In vivo.
Fisetin is the topic of his studies on Biochemistry and Flavonoid.
His Prostate cancer study deals with the bigger picture of Internal medicine.
His Pharmacology research incorporates elements of Lung cancer, Cardiotoxicity and Polyphenol.
Between 2013 and 2021, his most popular works were:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Targeting Microtubules by Natural Agents for Cancer Therapy (236 citations)
- Tea Polyphenols in Promotion of Human Health. (113 citations)
In his most recent research, the most cited papers focused on:
Cancer research, Pharmacology, Cancer, Fisetin and Cell growth are his primary areas of study.
His Cancer research study integrates concerns from other disciplines, such as Carcinogenesis, Immunology, Metastasis, Kinase and Prostate cancer.
His Pharmacology study combines topics in areas such as Mechanism of action, Internal medicine, Lung cancer, Cancer therapy and PI3K/AKT/mTOR pathway.
His work on Cancer prevention and Cancer cell as part of general Cancer study is frequently linked to Intervention, therefore connecting diverse disciplines of science.
His work deals with themes such as Apoptosis, Protein kinase B, DU145, Pathology and Melanoma, which intersect with Cell growth.
His research ties Nanocapsules and Biochemistry together.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
